Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...

In the closing of the recent trading day, Gilead Sciences (GILD) stood at $87.23, denoting a -1.05% change from the preceding trading day.

On Tuesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $88.16 which represents a slight increase of $1.87 or 2.17% from the prior close of $86.29. The stock opened at ...

The Center, Native Son, and Gilead present Black, Queer, & Here, a 2024 election forum on key issues facing the Black LGBTQ+ ...

Signaturefd LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.1% in the third ...

The healthcare sector has been a focal point for investors in 2024, offering a compelling blend of innovation-driven ...

A 33-year-old man presented to our dermatology clinic with a 1-month history of two painless ulcers on his right arm and ...

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

Eisenmenger Complex Management MarketThe global Eisenmenger Complex Management Market is poised for significant growth, projected to exceed USD 12.9 Billion by 2033, up from USD 7.7 Billion in 2023, ...

The Global Liver Fibrosis Treatment Industry, valued at USD 16.43 Billion in 2022, is on the brink of an extraordinary surge, ...

Eastern Bank purchased a new position in shares of SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY – Free Report) in the 3rd ...

September's investment activity was minimal, with $1,000 invested mainly in Business Development Companies. Check out my ...